Alkermes

Alkermes Breaks $1 Billion
Motley Fool
Tue, 02/19/19 - 12:18 pm
Alkermes
earnings
Alkermes shares take another hit as the FDA shakes its head — again — on a weak case for '5461
Endpoints
Fri, 02/1/19 - 10:41 pm
Alkermes
FDA
ALKS-5461
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Alkermes/Biogen hope for less tummy trouble with new MS pill
Pharmaforum
Tue, 12/18/18 - 10:28 am
Alkermes
Biogen
MS
multiple sclerosis
Vumerity
Alkermes Schizophrenia Drug Heads To FDA, But Questions Linger
Xconomy
Thu, 11/29/18 - 09:37 am
ALKS-3831
Alkermes
schizophrenia
FDA
[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
Motley Fool
Fri, 11/9/18 - 12:05 am
Alkermes
depression
ALSK-5461
opioids
Illumina
Pacific Biosciences
More data could be key for Alkermes after FDA panel vote
BioCentury
Sat, 11/3/18 - 03:59 pm
Alkermes
ALKS 5461
major depressive disorder
FDA
Alkermes Depression Drug Faces Long Odds After FDA Advisors Say No
Xconomy
Thu, 11/1/18 - 07:30 pm
Alkermes
FDA
advisory panels
ALKS-5461
major depressive disorder
FDA Blasts Data, Trial Design For Alkermes Depression Drug
Xconomy
Tue, 10/30/18 - 11:34 am
FDA
Alkermes
ALKS 5461
clinical trials
major depressive disorder
A double date with destiny for Alkermes
EP Vantage
Fri, 10/5/18 - 12:06 pm
Alkermes
FDA
clinical trials
ALKS 5461
ALKS 3831
Alkermes in pay-for-performance deal
BioCentury
Sat, 09/1/18 - 04:10 pm
Alkermes
UPMC
Vivitrol
opioids
opioid addiction
pay-for-performance
Alkermes, Oklahoma negotiating value-based Medicaid purchasing agreements
BioCentury
Sun, 08/26/18 - 11:58 am
Oklahoma
Medicaid
Alkermes
Aristada
schizophrenia
Collaborations Help Alkermes Flip to Profitability
Motley Fool
Fri, 07/27/18 - 07:09 pm
Alkermes
Biogen
earnings
FDA Now Accepts Alkermes Application It Rejected Two Weeks Ago
CP Wire
Mon, 04/16/18 - 09:05 am
Alkermes
ALKS-5461
major depressive disorder
FDA
FDA Now Accepts Alkermes Application It Rejected Two Weeks Ago
Mon, 04/16/18 - 08:52 am
Alkermes
ALKS-5461
Alkermes' Bad News Could Be Good News for Johnson & Johnson
Motley Fool
Wed, 04/4/18 - 10:07 pm
Alkermes
JNJ
ALKS-5461
esketamine
major depressive disorder
Why FDA News About Alkermes ALKS 5461 Studies Is Not A Complete Surprise
CP Wire
Mon, 04/2/18 - 09:37 am
Alkermes
FDA
ALKS 5461
clinical trials
Why FDA News About Alkermes ALKS 5461 Studies Is Not A Complete Surprise
Mon, 04/2/18 - 09:33 am
Alkermes
ALKS 5461
major depressive disorder
FDA Rejects Alkermes NDA for Major Depressive Disorder Drug ALKS 5461
CP Wire
Mon, 04/2/18 - 09:01 am
Alkermes
FDA
depression
major depressive disorder
ALKS 5461
Trump opioid plan writes in favoritism to single company’s addiction medication
Stat
Mon, 03/26/18 - 10:08 am
opioids
opioid crisis
opioid addiction
Donald Trump
Alkermes
Vivitrol

Pages